首页> 外国专利> Triterpenoid obtainable from hedera helix for treatment of neurodegenerative diseases

Triterpenoid obtainable from hedera helix for treatment of neurodegenerative diseases

机译:可得自hedera螺旋的三萜类化合物,用于治疗神经退行性疾病

摘要

A method for treating a subject suffering from a neurodegenerative disease includes administering at least one triterpenoid which can be obtained from Hedera helix. A method for treating a subject suffering from a neurodegenerative disease includes administering an effective amount of a Hedera helix extract which comprises the triterpenoid. The neurodegenerative disease is preferably but not exclusively Parkinson's disease or Huntington's disease. Methods for extracting the triterpenoid from Hedera helix and a method for inducing autophagy in cells by contacting them with the triterpenoid are also provided. The triterpenoid allows an exceptional induction of autophagy, in particular a significant reduction of the protein level of mutant huntingtin, a significant reduction of the protein level of A53T α-synuclein, a significant inhibition of the oligomerization of α-synuclein and a significant inhibition of the inclusion formation of huntingtin via the AMPK-mTOR dependent autophagy inducing pathway.
机译:一种治疗患有神经退行性疾病的对象的方法,包括施用至少一种可从 Hedera helix 获得的三萜。一种用于治疗患有神经退行性疾病的受试者的方法,包括给予有效量的包含三萜类化合物的 Hedera helix 提取物。神经退行性疾病优选但不仅限于帕金森氏病或亨廷顿氏病。还提供了从 Hedera helix 中提取三萜类化合物的方法,以及通过使细胞与三萜类化合物接触来诱导细胞自噬的方法。三萜类化合物可以异常诱导自噬,特别是显着降低突变型亨廷顿蛋白的水平,显着降低A53Tα-突触核蛋白的蛋白水平,显着抑制α-突触核蛋白的寡聚以及显着抑制α-突触核蛋白的寡聚化。通过依赖AMPK-mTOR的自噬诱导途径形成亨廷顿蛋白的包涵体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号